Get the Stockscreener App
67.65
2.77%
-1.93
After Hours:
67.65
Henry Schein Inc stock is traded at $67.65, with a volume of 1.78M.
It is down -2.77% in the last 24 hours and down -7.39% over the past month.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.
See More
Previous Close:
$69.58
Open:
$68.33
24h Volume:
1.78M
Relative Volume:
1.10
Market Cap:
$8.23B
Revenue:
$12.50B
Net Income/Loss:
$314.00M
P/E Ratio:
27.73
EPS:
2.44
Net Cash Flow:
$421.00M
1W Performance:
-6.84%
1M Performance:
-7.39%
6M Performance:
-15.44%
1Y Performance:
-5.96%
1-Day Range:
$67.45
$69.12
1-Week Range:
$67.45
$71.96
52-Week Range:
$60.56
$82.49
Henry Schein Inc Stock (HSIC) Company Profile
Name
Henry Schein Inc
Sector
Industry
Phone
(631) 843-5500
Address
135 DURYEA RD, MELVILLE, NY
Compare HSIC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
67.65 | 8.70B | 12.50B | 314.00M | 421.00M | 2.44 |
|
MCK
Mckesson Corporation
|
693.54 | 89.30B | 359.05B | 3.30B | 5.23B | 25.83 |
|
COR
Cencora Inc
|
286.08 | 56.56B | 310.23B | 1.69B | 3.58B | 8.62 |
|
CAH
Cardinal Health Inc
|
155.22 | 37.69B | 222.29B | 1.56B | 2.44B | 6.41 |
|
AHG
Akso Health Group Adr
|
1.699 | 662.04M | 2.22M | -5.63M | -1.68M | -0.24 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-25-25 | Downgrade | Stifel | Buy → Hold |
| Jul-14-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-14-25 | Initiated | Wells Fargo | Equal Weight |
| Jan-06-25 | Upgrade | BofA Securities | Underperform → Buy |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Jul-22-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-12-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-10-23 | Upgrade | Stifel | Hold → Buy |
| Aug-08-22 | Upgrade | UBS | Sell → Neutral |
| Jul-21-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-13-22 | Resumed | Credit Suisse | Outperform |
| Jan-31-22 | Initiated | Morgan Stanley | Underweight |
| Jan-07-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Oct-01-21 | Resumed | Credit Suisse | Neutral |
| Feb-08-21 | Resumed | Piper Sandler | Overweight |
| Jan-04-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-03-20 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| May-06-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Apr-07-20 | Upgrade | Goldman | Neutral → Buy |
| Apr-02-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-09-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-02-20 | Upgrade | Evercore ISI | Underperform → In-line |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| May-30-19 | Initiated | Wolfe Research | Underperform |
| May-15-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Jan-17-19 | Initiated | UBS | Sell |
| Jan-03-19 | Downgrade | Evercore ISI | In-line → Underperform |
| Jan-02-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Nov-08-18 | Reiterated | Barrington Research | Outperform |
| Oct-25-18 | Downgrade | Edward Jones | Hold → Sell |
| Oct-19-18 | Resumed | Goldman | Neutral |
| Oct-04-18 | Reiterated | Robert W. Baird | Outperform |
| Aug-07-18 | Reiterated | Stifel | Hold |
| Apr-24-18 | Downgrade | Goldman | Buy → Neutral |
| Apr-04-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
View All
Henry Schein Inc Stock (HSIC) Latest News
Board Approves Henry Schein Opioid Settlement and Buoy Permit Application - CitizenPortal.ai
Stock Analysis | Henry Schein OutlookMixed Signals Amid Industry Headwinds - AInvest
Henry Schein: Still Bullish Even As Shares Languish (NASDAQ:HSIC) - Seeking Alpha
What makes Henry Schein Inc. stock price move sharplyStock Market Forecasts For 2025 - jammulinksnews.com
HENRY SCHEIN INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Henry Schein, Inc. To Contact The Firm - ACCESS Newswire
Sector ETF Data Correlates with Strength in Henry Schein Inc.Alpha Driven Watchlist With Alerts Published - metal.it
Henry Schein One Launches Forms to Make Patient Check-In Easier and Faster - Business Wire
Henry Schein downgraded at Stifel on market share concerns - MSN
Bollinger Bands Expand on Henry Schein Inc. — Volatility AheadLow Capital High Return Stock Plans Reviewed - metal.it
Can Henry Schein Inc. Rally Enough to Break EvenAlpha Driven Watchlist With Alerts Published - metal.it
Henry Schein (HSIC) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release - Yahoo Finance
Henry Schein to Report Q2 Earnings: What's in Store for the Stock? - Yahoo Finance
Trend Reversal Possible in Henry Schein Inc. Charts IndicateLow Capital High Return Stock Plans Reviewed - metal.it
Should I hold or sell Henry Schein Inc. stock in 2025Access powerful market insights for free - jammulinksnews.com
How does Henry Schein Inc. compare to its industry peersFree Consultation - jammulinksnews.com
How does Henry Schein Inc. generate profit in a changing economyBreakthrough wealth creation - jammulinksnews.com
Is Henry Schein Inc. a growth stock or a value stockMaximize your returns with expert insights - jammulinksnews.com
What are analysts’ price targets for Henry Schein Inc. in the next 12 monthsMarket-leading capital gains - jammulinksnews.com
What is Henry Schein Inc. company’s growth strategyTrack stocks with high upside potential easily - jammulinksnews.com
How volatile is Henry Schein Inc. stock compared to the marketMaximize returns with strategic portfolio planning - jammulinksnews.com
Henry Schein Inc. Stock Analysis and ForecastUnmatched market gains - PrintWeekIndia
Henry Schein (HSIC) Downgraded Amid Market Share Concerns - GuruFocus
Henry Schein stock downgraded at Stifel (HSIC:NASDAQ) - Seeking Alpha
Henry Schein (HSIC) Downgraded by Stifel, Price Target Cut to $7 - GuruFocus
Henry Schein (HSIC) Downgraded by Stifel, Price Target Cut to $75 | HSIC Stock News - GuruFocus
Henry Schein stock downgraded by Stifel on market share concerns - Investing.com India
What drives Henry Schein Inc. stock pricePhenomenal returns - Autocar Professional
Stifel Adjusts Henry Schein (HSIC) Rating Amid Market Challenges - GuruFocus
Stifel Adjusts Henry Schein (HSIC) Rating Amid Market Challenges | HSIC Stock News - GuruFocus
Is Henry Schein Inc. a good long term investmentDynamic investment opportunities - PrintWeekIndia
Acadia Healthcare, Henry Schein, The Pennant Group, Ziff Davis, and Atlassian Shares Are Soaring, What You Need To Know - Yahoo Finance
Will CEO Succession Impact Henry Schein's (HSIC) Digital Transformation and Efficiency Goals? - simplywall.st
What analysts say about Henry Schein Inc. stockOutstanding trading profits - jammulinksnews.com
Lobbying Update: $20,000 of HENRY SCHEIN lobbying was just disclosed - Quiver Quantitative
Henry Schein Announces Q2 2025 Earnings Release and Conference Call - AInvest
Henry Schein to Webcast Second Quarter 2025 Conference Call on Tuesday, August 5, 2025, at 8:00 a.m. ET - Business Wire
Henry Schein's Quarterly Earnings Preview: What You Need to Know - MSN
Henry Schein Inc Stock (HSIC) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.35%
2.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):